Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanochemazone is a global supplier and manufacturer specializing in high-purity nanomaterials, advanced chemicals, and specialized materials for research and industrial applications. The company provides a diverse portfolio including carbon nanotubes, graphene, metal and metal oxide nanoparticles, and quantum dots. Their products serve various sectors such as biotechnology, electronics, energy, and pharmaceuticals, supporting both academic R&D and large-scale industrial production. Nanochemazone also offers custom synthesis and characterization services to meet specific client requirements in the life sciences and materials science fields. The company operates with a focus on providing high-quality materials that enable innovation in drug delivery, biosensing, and diagnostic technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanochemazone.